Sharepoint Solutions
PRODUCTS
-
Streamline your Trial Master File (TMF) documentation and integrate with study sites to accelerate trial timelines.
Other eTMFs promise ease of use and seamless integration with the sites eISF, but they can’t deliver 100% adoption.
-
Expediting the customer journey from discovery all the way through commercial release.
-
Review how a comprehensive cGMP manufacturing facility is poised to support the development and manufacture of your mammalian cell program.
-
ACS ATOMUS® PF8 features an NSF/ANSI 61 certified and proprietary filtration solution for the water treatment industry specifically designed to remove PFAS forever chemicals from drinking water.
-
It’s about time.
Modern ePRO/eCOA.
Solved.Don’t wait a lifetime to launch a study that’s just “good enough”. Build and design a data collection experience that patients and sites will love to use.
WHITE PAPERS AND CASE STUDIES
-
Fortrea Optimizes Site Matching On Retina Clinical Trials
Faced with challenges in engaging clinical trial sites within the retina research landscape, Fortrea sought a partnership that leverages RWD to streamline site feasibility assessments.
-
A Risk-Based Approach To Plasmid DNA And mRNA Process Development
Balancing robust analytics and clinical readiness is key for early-phase pDNA and mRNA therapeutics amid structural complexity and regulatory challenges.
-
Evansville Water & Sewer Utility: 4 Tactics For Managing & Organizing Vertical Assets
EWSU, serving 65,000 customers, revamped its vertical asset tracking with POWER Engineers to enhance maintenance workflows. Here's how they optimized their processes.
-
Building A High-Quality IND From Scratch With Strategic Gap Analysis
A biotech sponsor lacking in-house regulatory expertise engaged a partner to obtain strategic regulatory review, medical writing, project management, and electronic publishing (eCTD).
-
Taking Research In-House With CRIO: SciTech's Multi-Center Phase 1 Study
Explore the success story of an early-stage clinical pharmaceutical company that effectively navigated funding constraints when conducting its Phase 1 study without a third-party CRO.
-
Avoiding The Pitfalls Of PQR
Explore the fundamentals of Product Quality Reviews (PQRs), common challenges manufacturers face, strategies for streamlining PQRs, and solutions that aim to unlock the potential of a "real-time PQR."
-
Raise The Bar: Setting New Standards For The eCOA Industry
A paradigm shift may be necessary to increase the adoption of Electronic Clinical Outcome Assessments (eCOA) in clinical research. Explore six pivotal areas where eCOA standards can be improved.
-
Improving Patient Health And Safety
Engage an experienced CMC program management consultant to collaboratively develop and maintain a robust product development plan (PDP) with your team lead, cross-functional members, and vendors.
-
Organizational Assessment For A Large MedTech Company
Explore an organizational assessment run for a medical technology company specializing in tissue repair and regeneration, and the actionable recommendations provided to facilitate future growth.
-
Expanding Diabetes-Related Eye Health Equity
20/20 Onsite, American Diabetes Association and Genentech collaborated on an event to provide immediate diagnostic services, including retinal imaging and visual acuity assessments, directly on-site.
-
Reducing Risk And Timelines In Cell Line Development
Accelerate your biologic development by adopting faster, more reliable clone selection methods that reduce time and resources while improving the likelihood of identifying stable, high-producing cell lines.
-
Patient-Focused Data Capture For Cancer Research
In a field where innovation is constant and patient experience is pivotal, oncology demands eCOA solutions designed to balance scientific rigor with human realities.
NEWS
-
Ohio Sea Grant Releases 2025 Summary Of ODHE Harmful Algal Bloom Research Initiative12/18/2025
Ohio Sea Grant, on behalf of The Ohio State University, The University of Toledo and the Ohio Department of Higher Education (ODHE), has released the 2025 research findings update for the statewide Harmful Algal Bloom Research Initiative (HABRI).
-
Diasorin Submits The LIAISON NES Point-Of-Care Molecular Diagnostics System And 4-Plex Respiratory Panel To The FDA For 510(k) Clearance And CLIA Waiver7/2/2025
Diasorin announces the submission of a 510(k) premarket notification and CLIA waiver application to the U.S. Food and Drug Administration (FDA) for its LIAISON NES, a next-generation molecular POC testing platform.
-
Egetis Therapeutics Initiates New Drug Application In The USA For Emcitate (Tiratricol) For MCT8 Deficiency12/19/2025
Egetis Therapeutics AB (publ) (“Egetis” or the “Company”), today announced that the Company has initiated a rolling New Drug Application (NDA) submission to the U.S. Food and Drug Administration (FDA) for Emcitate (tiratricol), its investigational drug for the treatment of MCT8 deficiency.
-
New UNECE Study Identifies Priorities To Address Staffing Shortages In The Water Sector6/20/2025
Managing climate change impacts on water resources including floods and droughts, as well as competing demands from different sectors on dwindling resources and pollution, requires adequate human resources in the water sector.
-
CCC, Purifics Provide World's Most Advanced Oxidation Process To U.S. Navy10/20/2025
CCC is pleased to announce that it was awarded a contract by the United States Department of War (U.S. DoD) to provide the most advanced Photo-Cat Oxidation system available to the U.S. Navy.